The resolution calls for the Utah Department of Health and Human Services to enhance statewide data collection and reporting related to NAS and prenatal substance exposure. This initiative aims to facilitate better understanding of incidence rates and maternal-infant health outcomes associated with NAS, ultimately leading to improved program initiatives. As a result, public health policies may be strengthened to comprehensively address the growing prevalence of NAS and the underlying issues of substance use during pregnancy.
Summary
HJR011, also known as the Joint Resolution Recognizing Neonatal Abstinence Syndrome, aims to bring attention to the critical health issue of neonatal abstinence syndrome (NAS) affecting newborns due to in-utero exposure to addictive substances, particularly opioids. The resolution outlines the importance of recognizing and properly managing NAS to prevent serious complications such as prolonged hospital stays and feeding difficulties. It emphasizes the need for ongoing efforts within the state to support effective prevention, treatment, and care strategies tailored for mothers and infants impacted by this condition.
Contention
While HJR011 seeks to address a significant public health concern, discussions around it highlight the challenges healthcare providers face in terms of stigma attached to prenatal substance exposure. Moreover, there are ongoing debates about the adequacy of current prevention and treatment programs, as well as how to balance effective support for affected families while ensuring the health of infants. The resolution opens the door for potential legislative actions aimed at reducing adverse effects associated with substance exposure during pregnancy, fostering a multi-faceted approach in tackling this issue.
Controlled substances: other; sentencing guidelines for retail sale of products containing ephedrine or pseudoephedrine; modify. Amends sec. 13m, ch. XVII of 1927 PA 175 (MCL 777.13m). TIE BAR WITH: HB 4947'25
Criminal procedure: sentencing guidelines; sentencing guidelines for illicit use of xylazine; provide for. Amends sec. 13m, ch. XVII of 1927 PA 175 (MCL 777.13m).
Criminal procedure: sentencing guidelines; sentencing guidelines for delivering, manufacturing, or possessing with intent to deliver certain controlled substances; amend. Amends sec. 13m, ch. XVII of 1927 PA 175 (MCL 777.13m). TIE BAR WITH: HB 4255'25